EIF4E and neoplasm: Conversely, mice administered with EVs derived from eIF4E KD ID8 Trp53−/−;Brca2−/− cells exhibited decelerated tumor growth when compared to those receiving EVs from ID8 Trp53−/−;Brca2−/− cells (Figure 6C,D and Figure S6C,D, Supporting Information).